A detailed history of Plimoth Trust CO LLC transactions in Novartis Ag stock. As of the latest transaction made, Plimoth Trust CO LLC holds 2,148 shares of NVS stock, worth $235,871. This represents 0.05% of its overall portfolio holdings.

Number of Shares
2,148
Previous 2,148 -0.0%
Holding current value
$235,871
Previous $247,000 15.38%
% of portfolio
0.05%
Previous 0.06%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$106.13 - $120.89 $227,967 - $259,671
2,148 New
2,148 $247,000
Q2 2022

Jul 15, 2022

SELL
$80.52 - $93.75 $14,252 - $16,593
-177 Reduced 5.91%
2,820 $239,000
Q1 2022

Apr 25, 2022

SELL
$80.11 - $90.62 $2,162 - $2,446
-27 Reduced 0.89%
2,997 $263,000
Q4 2021

Jan 27, 2022

SELL
$79.7 - $88.13 $6,376 - $7,050
-80 Reduced 2.58%
3,024 $265,000
Q3 2021

Oct 22, 2021

SELL
$81.78 - $95.14 $16,764 - $19,503
-205 Reduced 6.2%
3,104 $254,000
Q2 2021

Jul 20, 2021

SELL
$85.24 - $94.15 $1,704 - $1,883
-20 Reduced 0.6%
3,309 $302,000
Q1 2021

Apr 14, 2021

SELL
$83.5 - $98.47 $56,780 - $66,959
-680 Reduced 16.96%
3,329 $284,000
Q4 2020

Jan 22, 2021

SELL
$78.07 - $94.43 $87,672 - $106,044
-1,123 Reduced 21.88%
4,009 $378,000
Q3 2020

Oct 27, 2020

SELL
$82.14 - $91.0 $54,212 - $60,060
-660 Reduced 11.4%
5,132 $446,000
Q2 2020

Jul 20, 2020

SELL
$80.93 - $91.1 $78,178 - $88,002
-966 Reduced 14.29%
5,792 $505,000
Q1 2020

Apr 22, 2020

SELL
$70.67 - $99.01 $90,457 - $126,732
-1,280 Reduced 15.92%
6,758 $558,000
Q4 2019

Jan 29, 2020

SELL
$84.35 - $95.37 $75,324 - $85,165
-893 Reduced 10.0%
8,038 $761,000
Q3 2019

Oct 28, 2019

SELL
$85.54 - $94.26 $78,269 - $86,247
-915 Reduced 9.29%
8,931 $776,000
Q2 2019

Aug 05, 2019

SELL
$75.4 - $92.8 $135,343 - $166,576
-1,795 Reduced 15.42%
9,846 $899,000
Q1 2019

Apr 19, 2019

SELL
$75.32 - $86.15 $84,283 - $96,401
-1,119 Reduced 8.77%
11,641 $1.12 Million
Q4 2018

Jan 25, 2019

SELL
$73.66 - $82.02 $70,860 - $78,903
-962 Reduced 7.01%
12,760 $1.1 Million
Q3 2018

Dec 13, 2018

SELL
$66.94 - $77.43 $101,079 - $116,919
-1,510 Reduced 9.91%
13,722 $1.18 Million
Q2 2018

Dec 12, 2018

SELL
$64.91 - $73.36 $190,835 - $215,678
-2,940 Reduced 16.18%
15,232 $1.15 Million
Q1 2018

Dec 21, 2018

SELL
$70.39 - $84.15 $34,631 - $41,401
-492 Reduced 2.64%
18,172 $1.47 Million
Q4 2017

Dec 26, 2018

BUY
$72.33 - $77.64 $1.35 Million - $1.45 Million
18,664
18,664 $1.57 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $236B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Plimoth Trust CO LLC Portfolio

Follow Plimoth Trust CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Plimoth Trust CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Plimoth Trust CO LLC with notifications on news.